Growth inhibition and apoptosis in cancer cells induced by polyphenolic compounds of Acacia hydaspica: Involvement of multiple signal transduction pathways

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Afsar, Tayyaba ^a   Trembley, Janeen H ^b,c   Salomon, Christine E ^d   Razak, Suhail ^a   Khan, Muhammad Rashid ^a   Ahmed, Khalil ^b,c  

^a QUAID I AZAM UNIVERSITY   (Pakistan)

^b VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIRC5 PROTEIN, HUMAN; CATECHIN; CATECHIN GALLATE; GALLIC ACID; GALLIC ACID METHYL ESTER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; POLYPHENOL; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN KINASE B; X LINKED INHIBITOR OF APOPTOSIS; XIAP PROTEIN, HUMAN;

ACACIA; ANALOGS AND DERIVATIVES; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

ACACIA; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; CATECHIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GALLIC ACID; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICROSCOPY, FLUORESCENCE; MOLECULAR STRUCTURE; NEOPLASMS; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; POLYPHENOLS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84960968227     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23077     Document Type: Article

References (44)

1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2015. CA. Cancer J. Clin. 65, 5-29 (2015).
2. Global Burden of Disease Cancer, C. et al. The Global Burden of Cancer 2013. JAMA Oncol 1, 505-527 (2015).
3. Armstrong, C. M. & Gao, A. C. Drug resistance in castration resistant prostate cancer: resistance mechanisms and emerging treatment strategies. Am J Clin Exp Urol 3, 64-76 (2015).
4. Skibinski, A. & Kuperwasser, C. The origin of breast tumor heterogeneity. Oncogene 34, 5309-5316 (2015).
5. Alimirah, F., Chen, J., Basrawala, Z., Xin, H. & Choubey, D. DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation. FEBS Lett. 580, 2294-2300 (2006).
6. Lehmann, B. D. et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. The Journal of clinical investigation 121, 2750 (2011).
7. Surh, Y. J. Cancer chemoprevention with dietary phytochemicals. Nature reviews. Cancer 3, 768-780 (2003).
8. Ahmad, N. & Mukhtar, H. Green tea polyphenols and cancer: biologic mechanisms and practical implications. Nutr. Rev. 57, 78-83 (1999).
9. Siddiqui, I. A. et al. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res. 69, 1712-1716 (2009).
10. Murtaza, I., Saleem, M., Adhami, V. M., Hafeez, B. B. & Mukhtar, H. Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells. Cancer Res. 69, 1156-1165 (2009).
11. Khan, N., Afaq, F., Saleem, M., Ahmad, N. & Mukhtar, H. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res. 66, 2500-2505 (2006).
12. Hafeez, B. B. et al. A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling. Cancer Res. 68, 8564-8572 (2008).
13. Khan, N., Afaq, F., Kweon, M. H., Kim, K. & Mukhtar, H. Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Cancer Res. 67, 3475-3482 (2007).
14. Khan, N., Asim, M., Afaq, F., Abu Zaid, M. & Mukhtar, H. A novel dietary flavonoid fisetin inhibits androgen receptor signaling and tumor growth in athymic nude mice. Cancer Res. 68, 8555-8563 (2008).
15. Malviya, S., Rawat, S., Kharia, A. & Verma, M. Medicinal attributes of Acacia nilotica Linn.-A comprehensive review on ethnopharmacological claims. Int. J. of Pharm. & Life Sci.(IJPLS) 2, 830-837 (2011).
16. Kim, I. & He, Y. Y. Targeting the AMP-Activated Protein Kinase for Cancer Prevention and Therapy. Frontiers in oncology 3, 175 (2013).
17. Zargari, A. Iranian medicinal plants. Tehran: Tehran University Publications (1997).
18. Ghate, N. B., Hazra, B., Sarkar, R. & Mandal, N. Heartwood extract of Acacia catechu induces apoptosis in human breast carcinoma by altering bax/bcl-2 ratio. Pharmacognosy magazine 10, 27 (2014).
19. Aliyu, M. et al. Acacia honey modulates cell cycle progression, pro-inflammatory cytokines and calcium ions secretion in PC-3 cell line. Cancer Science & Theraphy 4, 401-407 (2012).
20. Nishioka, T., Kawabata, J. & Aoyama, Y. Baicalein, an α-glucosidase inhibitor from Scutellaria baicalensis. Journal of natural products 61, 1413-1415 (1998).
21. Tanaka, T., Nonaka, G.-I. & Nishioka, I. 7-O-galloyl-(+ )-catechin and 3-O-galloylprocyanidin B-3 from Sanguisorba officinalis. Phytochemistry 22, 2575-2578 (1983).
22. Nonaka, G.-i., Morimoto, S. & Nishioka, I. Tannins and related compounds. Part 13. Isolation and structures of trimeric, tetrameric, and pentameric proanthicyanidins from cinnamon. Journal of the Chemical Society, Perkin Transactions 1, 2139-2145 (1983).
23. Shen, C.-C., Chang, Y.-S. & Hott, L.-K. Nuclear magnetic resonance studies of 5, 7-dihydroxyflavonoids. Phytochemistry 34, 843-845 (1993).
24. Min-Won, L., Morimoto, S., Nonaka, G.-I. & Nishioka, I. Flavan-3-ol gallates and proanthocyanidins from Pithecellobium lobatum. Phytochemistry 31, 2117-2120 (1992).
25. Hacker, G. The morphology of apoptosis. Cell and tissue research 301, 5-17 (2000).
26. Baskic, D., Popovic, S., Ristic, P. & Arsenijevic, N. N. Analysis of cycloheximide-induced apoptosis in human leukocytes: fluorescence microscopy using annexin V/propidium iodide versus acridin orange/ethidium bromide. Cell Biol. Int. 30, 924-932 (2006).
27. Ahmad, K. A. et al. Protein kinase CK2 modulates apoptosis induced by resveratrol and epigallocatechin-3-gallate in prostate cancer cells. Molecular Cancer Therapeutics 6, 1006-1012 (2007).
28. Le Marchand, L. Cancer preventive effects of flavonoids-a review. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 56, 296-301 (2002).
29. Cohen, J. H., Kristal, A. R. & Stanford, J. L. Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst 92, 61-68 (2000).
30. Thiery-Vuillemin, A. et al. Molecularly targeted agents: their promise as cancer chemopreventive interventions. Eur J Cancer 41, 2003-2015 (2005).
31. Yang, C. S., Landau, J. M., Huang, M.-T. & Newmark, H. L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annual review of nutrition 21, 381-406 (2001).
32. Hoffmann, A. & Baltimore, D. Circuitry of nuclear factor kappaB signaling. Immunological reviews 210, 171-186 (2006).
33. Vazquez, F. et al. Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J. Biol. Chem. 276, 48627-48630 (2001).
34. Di Maira, G., Brustolon, F., Pinna, L. & Ruzzene, M. Dephosphorylation and inactivation of Akt/PKB is counteracted by protein kinase CK2 in HEK 293T cells. Cell. Mol. Life Sci. 66, 3363-3373 (2009).
35. Steelman, L. S. et al. Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging 3, 192-222 (2011).
36. Zheng, Y. et al. A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway. Blood 118, 156-166 (2011).
37. Gray, G. K., McFarland, B. C., Rowse, A. L., Gibson, S. A. & Benveniste, E. N. Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells. Oncotarget 5, 6484-6496 (2014).
38. Sethi, G., Ahn, K. S. & Aggarwal, B. B. Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Molecular cancer research 6, 1059-1070 (2008).
39. Catz, S. D. & Johnson, J. L. Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene 20, 7342-7351 (2001).
40. Altieri, D. C. Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8, 61-70 (2008).
41. Kanwar, R. K., Cheung, C. H., Chang, J. Y. & Kanwar, J. R. Recent advances in anti-survivin treatments for cancer. Curr Med Chem 17, 1509-1515 (2010).
42. Jha, K., Shukla, M. & Pandey, M. Survivin expression and targeting in breast cancer. Surg. Oncol. 21, 125-131 (2012).
43. Qaiser, F. et al. Protein Kinase CK2 Inhibition Induces Cell Death via Early Impact on Mitochondrial Function. J. Cell. Biochem. 115, 2103-2115 (2014).
44. Trembley, J. H. et al. Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α ' subunits reduces orthotopic xenograft prostate tumors in mice. Molecular and cellular biochemistry 356, 21-35 (2011).